The University Of Colorado Denver Anschutz Medical Campus
The University Of Colorado Denver Anschutz Medical Campus is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease
Sponsor Adarx Pharmaceuticals Inc.
- Start (EU)
- Latest update
- Estimated end
Proof of concept study to assess the efficacy and safety of Danicopan (factor D inhibitor) in adult patients with chronic spontaneous urticaria resistant to H1-antihistamine treatment (DANICSU).
Sponsor Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
- Start (EU)
- Not reported
- Latest update
- Estimated end
- Not reported
Operational learnings available2 trial-level findings · Read insights
- No study centers were initiated before the end-of-trial notification on 20 October 2024.
- No patients were enrolled before the end-of-trial notification on 20 October 2024.
These findings describe the trial, not the service provider’s performance or responsibility.
A Phase 2, Open-label, Multicenter, Randomized Study to Evaluate the Persistence, Safety, and Acceptability of Twice Yearly Long-acting Subcutaneous Lenacapavir for HIV Pre-Exposure Prophylaxis (PrEP) in People Who Would Benefit from PrEP
Sponsor Gilead Sciences Inc.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for The University Of Colorado Denver Anschutz Medical Campus?
The 2026-10-09 snapshot links The University Of Colorado Denver Anschutz Medical Campus to 3 distinct CTIS trials. Recorded services include Laboratory services, Dried Blood Spot (DBS) analysis. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for The University Of Colorado Denver Anschutz Medical Campus?
The most frequently recorded therapeutic areas are Immunology, Allergy, Dermatology, Nephrology. Recorded phases include Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to The University Of Colorado Denver Anschutz Medical Campus conducted?
The linked trials record locations in 4 countries, including Germany, Spain, France, Italy. These are trial locations, not confirmed office locations or countries where The University Of Colorado Denver Anschutz Medical Campus delivered services.
What can this page tell me about The University Of Colorado Denver Anschutz Medical Campus's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. 1 trials have operational findings that can inform further due diligence. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under The University Of Colorado Denver Anschutz Medical Campus. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- The University Of Colorado Denver Anschutz Medical Campus